Singapore, Aug. 11 -- Merck, a leading science and technology company, is expanding its Singapore lab to further strengthen analytical and biosafety testing services for customers across the Asia Pacific region. Biosafety testing is a critical step in the drug development and manufacturing process, helping to ensure that biologics are safe, effective, and compliant with regulatory requirements.The expansion builds on Merck's global testing expertise of more than 75 years and marks a significant milestone in providing an advanced, local contract testing services portfolio for the region's growing biopharma industry.

Merck's Singapore laboratory will become the first BioReliance(R) facility in Asia-Pacific to offer both Cell Line Character...